Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Home |
Description | News & Home Page Toggle navigation AURORA BioPharma About Us Management Scientific Advisors Collaborations --> Technology Our Platform Glioblastoma --> M |
Keywords | N/A |
WebSite | aurora-biopharma.com |
Host IP | 74.208.236.147 |
Location | United States |
Site | Rank |
US$262,784
Last updated: 2023-05-08 03:11:49
aurora-biopharma.com has Semrush global rank of 40,277,657. aurora-biopharma.com has an estimated worth of US$ 262,784, based on its estimated Ads revenue. aurora-biopharma.com receives approximately 30,322 unique visitors each day. Its web server is located in United States, with IP address 74.208.236.147. According to SiteAdvisor, aurora-biopharma.com is safe to visit. |
Purchase/Sale Value | US$262,784 |
Daily Ads Revenue | US$243 |
Monthly Ads Revenue | US$7,278 |
Yearly Ads Revenue | US$87,325 |
Daily Unique Visitors | 2,022 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
aurora-biopharma.com. | A | 3599 | IP: 74.208.236.147 |
aurora-biopharma.com. | AAAA | 3599 | IPV6: 2607:f1c0:100f:f000::2c4 |
aurora-biopharma.com. | NS | 86400 | NS Record: ns-us.1and1-dns.com. |
aurora-biopharma.com. | NS | 86400 | NS Record: ns-us.1and1-dns.org. |
aurora-biopharma.com. | NS | 86400 | NS Record: ns-us.1and1-dns.de. |
aurora-biopharma.com. | NS | 86400 | NS Record: ns-us.1and1-dns.us. |
aurora-biopharma.com. | MX | 3600 | MX Record: 10 mx00.1and1.com. |
aurora-biopharma.com. | MX | 3600 | MX Record: 10 mx01.1and1.com. |
Home Page Toggle navigation AURORA BioPharma About Us Management Scientific Advisors Collaborations --> Technology Our Platform Glioblastoma --> Media Investors --> NON-DISCLOSURE AND CONFIDENTIALITY AGREEMENT --> AGREEMENT SIGNATURE --> COMPANY OFFERING FOR INVESTORS IRA/401K INVESTMENT --> Contact INNOVATIVE CANCER IMMUNOTHERAPY Aurora is developing first-in-class therapies for resistant life-threatening solid tumor Learn more --> INNOVATIVE CANCER IMMUNOTHERAPY Aurora is developing first-in-class therapies for resistant life-threatening solid tumor Learn more --> INNOVATIVE CANCER IMMUNOTHERAPY Aurora is developing first-in-class therapies for resistant life-threatening solid tumor Learn more --> INNOVATIVE CANCER IMMUNOTHERAPY Aurora is developing first-in-class therapies for resistant life-threatening solid tumor Learn more --> Overview Aurora pioneer in the disruptive new medicine of genetically reengineering immune cells to kill cancer, and to |
HTTP/1.1 200 OK Content-Type: text/html Content-Length: 16533 Connection: keep-alive Keep-Alive: timeout=15 Date: Fri, 29 Oct 2021 05:53:40 GMT Server: Apache Last-Modified: Mon, 25 Nov 2019 16:37:20 GMT ETag: "4095-5982e60975000" Accept-Ranges: bytes |
Domain Name: AURORA-BIOPHARMA.COM Registry Domain ID: 2014912934_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-03-24T19:23:24Z Creation Date: 2016-03-23T17:51:19Z Registry Expiry Date: 2022-03-23T17:51:19Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-US.1AND1-DNS.COM Name Server: NS-US.1AND1-DNS.DE Name Server: NS-US.1AND1-DNS.ORG Name Server: NS-US.1AND1-DNS.US DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T20:19:22Z <<< |